ATE276274T1 - Konjugate von alpha-msh mit einer fettsäure, verfahren zu ihrer herstellung und ihre verwendung als medikament - Google Patents

Konjugate von alpha-msh mit einer fettsäure, verfahren zu ihrer herstellung und ihre verwendung als medikament

Info

Publication number
ATE276274T1
ATE276274T1 AT96922103T AT96922103T ATE276274T1 AT E276274 T1 ATE276274 T1 AT E276274T1 AT 96922103 T AT96922103 T AT 96922103T AT 96922103 T AT96922103 T AT 96922103T AT E276274 T1 ATE276274 T1 AT E276274T1
Authority
AT
Austria
Prior art keywords
alpha
msh
sequence
amino
acids
Prior art date
Application number
AT96922103T
Other languages
English (en)
Inventor
D Hinterland Lucien Dussourd
Anne-Marie Pinel
Original Assignee
Inst Europeen Biolog Cellulair
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Europeen Biolog Cellulair filed Critical Inst Europeen Biolog Cellulair
Application granted granted Critical
Publication of ATE276274T1 publication Critical patent/ATE276274T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT96922103T 1995-06-12 1996-06-12 Konjugate von alpha-msh mit einer fettsäure, verfahren zu ihrer herstellung und ihre verwendung als medikament ATE276274T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9506909A FR2735131B1 (fr) 1995-06-12 1995-06-12 Conjugues d'msh avec un acide gras, leur procede de preparation et leur utilisation a titre de medicament
PCT/FR1996/000890 WO1996041815A2 (fr) 1995-06-12 1996-06-12 CONJUGUES D'αMSH AVEC UN ACIDE GRAS, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT

Publications (1)

Publication Number Publication Date
ATE276274T1 true ATE276274T1 (de) 2004-10-15

Family

ID=9479857

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96922103T ATE276274T1 (de) 1995-06-12 1996-06-12 Konjugate von alpha-msh mit einer fettsäure, verfahren zu ihrer herstellung und ihre verwendung als medikament

Country Status (8)

Country Link
EP (1) EP0837881B1 (de)
JP (1) JPH11507661A (de)
AT (1) ATE276274T1 (de)
AU (1) AU6309496A (de)
DE (1) DE69633391T2 (de)
ES (1) ES2227597T3 (de)
FR (1) FR2735131B1 (de)
WO (1) WO1996041815A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176279B2 (en) 2000-06-28 2007-02-13 Palatin Technologies, Inc. Cyclic peptide compositions and methods for treatment of sexual dysfunction
EP1593384A3 (de) * 1999-06-29 2006-04-26 Palatin Technologies, Inc. Verbindungen zur Behandlung von sexuellen Funktionsstörungen
US6579968B1 (en) * 1999-06-29 2003-06-17 Palatin Technologies, Inc. Compositions and methods for treatment of sexual dysfunction
GB9930026D0 (en) * 1999-12-21 2000-02-09 Univ Sheffield Novel compounds of unsaturated fatty acids
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7166578B2 (en) 2000-08-24 2007-01-23 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7144862B2 (en) 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
WO2002083176A2 (en) * 2001-04-17 2002-10-24 University Of Sheffield Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming
KR20070089996A (ko) 2004-12-06 2007-09-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 세동맥의 구조 및 기능의 개선 방법
JPWO2009014105A1 (ja) * 2007-07-20 2010-10-07 株式会社山田養蜂場本社 新規カルボン酸およびそれを有効成分とする抗うつ用組成物
JP5715104B2 (ja) * 2012-09-27 2015-05-07 アブビー インコーポレイティド 治療的に活性なα−MSHアナログ
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
US11590209B2 (en) 2020-01-21 2023-02-28 Palatin Technologies, Inc. Use of bremelanotide in patients with controlled hypertension

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389950A1 (de) * 1989-03-23 1990-10-03 Lion Corporation Inhibitor des melanocytenstimulierenden Hormons und dieses enthaltendes, äusserlich anwendbares Präparat
CA2070061C (en) * 1991-06-07 2004-02-10 Shigeyuki Takama Physiologically active polypeptide-containing pharmaceutical composition
FR2691465B1 (fr) * 1992-05-25 1995-08-11 Pf Medicament Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant.
FR2710340B1 (fr) * 1993-09-22 1995-12-15 D Hinterland Lucien Dussourd Dérivés peptidiques de l'alpha-MSH et leur application .

Also Published As

Publication number Publication date
ES2227597T3 (es) 2005-04-01
EP0837881A2 (de) 1998-04-29
FR2735131B1 (fr) 1997-08-22
JPH11507661A (ja) 1999-07-06
WO1996041815A2 (fr) 1996-12-27
AU6309496A (en) 1997-01-09
WO1996041815A3 (fr) 1997-01-30
DE69633391D1 (de) 2004-10-21
FR2735131A1 (fr) 1996-12-13
EP0837881B1 (de) 2004-09-15
DE69633391T2 (de) 2005-02-24

Similar Documents

Publication Publication Date Title
DE69633391D1 (de) KONJUGATE VON alpha-MSH MIT EINER FETTSÄURE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS MEDIKAMENT
TW357146B (en) Tetrahydrofuran antifungals
CO4520232A1 (es) Conjugados de interferon-polimero y proceso para preparar el mismo
DE69423911D1 (de) Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut
ATE174604T1 (de) Lipopeptide aus actinoplanes sp. mit pharmakologischer wirkung, verfahren zu ihrer herstellung und verwendung derselben
ATE145649T1 (de) Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon
NZ290757A (en) Delivery of nucleic acid into a cell
CH692199A8 (fr) Composes pyridiques et compositions pharmaceutique
DE3885928D1 (de) Verfahren zur Herstellung von parenteral verabreichbaren Chinoloncarbonsäuren.
IT1277596B1 (it) Composti macromolecolari di tipo dendrimerico
ATE201961T1 (de) An polyungesättigten fettsäuren reiche triglyceride
IT1249732B (it) Oligonucleotidi antisenso.
YU108691A (sh) Nove 3,3'-ditiobis (propionske kiseline) i njihovi estri
IT1254996B (it) Esteri amminoalchilcarbammici dell'eserolina atti all'impiego come anticolinesterasici e relativo procedimento di preparazione
ATE271078T1 (de) Copolymere mit amphiphilen untereinheiten, verfahren zu deren herstellung und deren verwendung
ES2058047T3 (es) Resolucion de acido arilalcanoico.
EP0366041A3 (de) Imido-percarbonsäuren
ATE27464T1 (de) Herstellung von ursodeoxycholsaeurekonjugaten.
FR2491922B1 (de)
ATE32229T1 (de) Carboxylmodifizierte vinylesterurethan-harze, ihre anwendung und verwertung.
KR840002346A (ko) 펩타이드의 제조방법
KR850000468A (ko) 사이클릭 펩타이드의 제조방법
IT1176405B (it) Procedimento per produrre l-amminoacidi da alfa-chetoacidi mediante fermentazione
FI905930A0 (fi) Menetelmä uusien, farmakologisesti käyttökelpoisten bispilokarpiinihapon esterijohdannaisten valmistamiseksi
ATE224373T1 (de) Verfahren zur herstellung von alkylimidazolidinon(meth)acrylaten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties